Post-Transcriptional Regulation of Connexin43 in H-Ras-Transformed Cells

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Kandouz, Mustapha ^a,b   Zhao, Jing ^c   Bier, Andrew ^c   Di Marco, Sergio ^d   Oviedo Landaverde, Irene ^c   Gallouzi, Imed Eddine ^d   Batist, Gerald ^c  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

^c MCGILL UNIVERSITY   (Canada)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CONNEXIN 43; EPIDERMAL GROWTH FACTOR RECEPTOR 2; H RAS PROTEIN; MESSENGER RNA; PROTEIN TYROSINE KINASE; RAS PROTEIN; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ANIMAL CELL; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CX43 GENE; GENE EXPRESSION REGULATION; GENE SILENCING; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN RNA BINDING; REGULATORY SEQUENCE; RNA STABILITY; RNA TRANSLATION; TRANSCRIPTION REGULATION;

3' UNTRANSLATED REGIONS; 5' UNTRANSLATED REGIONS; ANIMALS; CONNEXIN 43; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE ORDER; GENES, ERBB-2; GENES, RAS; GENES, REPORTER; GENES, SRC; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS; INTERMEDIATE FILAMENTS; MICE; MODELS, BIOLOGICAL; NIH 3T3 CELLS; REGULATORY SEQUENCES, NUCLEIC ACID; RNA PROCESSING, POST-TRANSCRIPTIONAL; TRANSCRIPTIONAL ACTIVATION;

EID: 84874834604     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0058500     Document Type: Article

References (77)

1. Karnoub AE, Weinberg RA, (2008) Ras oncogenes: split personalities. Nat Rev Mol Cell Biol 9: 517-531.
2. Lundberg AS, Randell SH, Stewart SA, Elenbaas B, Hartwell KA, et al. (2002) Immortalization and transformation of primary human airway epithelial cells by gene transfer. Oncogene 21: 4577-4586.
3. Raponi M, Winkler H, Dracopoli NC, (2008) KRAS mutations predict response to EGFR inhibitors. Curr Opin Pharmacol 8: 413-418.
4. Barbacid M, (1987) ras genes. Annu Rev Biochem 56: 779-827.
5. Bos JL, (1989) ras oncogenes in human cancer: a review. Cancer Res 49: 4682-4689.
6. Rinker-Schaeffer CW, Graff JR, De Benedetti A, Zimmer SG, Rhoads RE, (1993) Decreasing the level of translation initiation factor 4E with antisense RNA causes reversal of ras-mediated transformation and tumorigenesis of cloned rat embryo fibroblasts. Int J Cancer 55: 841-847.
7. Prendergast GC, Davide JP, Lebowitz PF, Wechsler-Reya R, Kohl NE, (1996) Resistance of a variant ras-transformed cell line to phenotypic reversion by farnesyl transferase inhibitors. Cancer Res 56: 2626-2632.
8. Rayter SI (1989) Biochemical functions of oncogenes. Oncogene 113-189.
9. Macaluso M, Russo G, Cinti C, Bazan V, Gebbia N, et al. (2002) Ras family genes: an interesting link between cell cycle and cancer. J Cell Physiol 192: 125-130.
10. Satoh T, Endo M, Nakafuku M, Akiyama T, Yamamoto T, et al. (1990) Accumulation of p21ras.GTP in response to stimulation with epidermal growth factor and oncogene products with tyrosine kinase activity. Proc Natl Acad Sci U S A 87: 7926-7929.
11. Galang CK, Garcia-Ramirez J, Solski PA, Westwick JK, Der CJ, et al. (1996) Oncogenic Neu/ErbB-2 increases ets, AP-1, and NF-kappaB-dependent gene expression, and inhibiting ets activation blocks Neu-mediated cellular transformation. J Biol Chem 271: 7992-7998.
12. von Lintig FC, Dreilinger AD, Varki NM, Wallace AM, Casteel DE, et al. (2000) Ras activation in human breast cancer. Breast Cancer Res Treat 62: 51-62.
13. Eckert LB, Repasky GA, Ulku AS, McFall A, Zhou H, et al. (2004) Involvement of Ras activation in human breast cancer cell signaling, invasion, and anoikis. Cancer Res 64: 4585-4592.
14. Rajasekhar VK, Viale A, Socci ND, Wiedmann M, Hu X, et al. (2003) Oncogenic Ras and Akt signaling contribute to glioblastoma formation by differential recruitment of existing mRNAs to polysomes. Mol Cell 12: 889-901.
15. Bier A, Oviedo-Landaverde I, Zhao J, Mamane Y, Kandouz M, et al. (2009) Connexin43 pseudogene in breast cancer cells offers a novel therapeutic target. Mol Cancer Ther 8: 786-793.
16. Bruzzone R, White TW, Paul DL, (1996) Connections with connexins: the molecular basis of direct intercellular signaling. Eur J Biochem 238: 1-27.
17. Zhu D, Caveney S, Kidder GM, Naus CC, (1991) Transfection of C6 glioma cells with connexin 43 cDNA: analysis of expression, intercellular coupling, and cell proliferation. Proc Natl Acad Sci U S A 88: 1883-1887.
18. Zhu D, Kidder GM, Caveney S, Naus CC, (1992) Growth retardation in glioma cells cocultured with cells overexpressing a gap junction protein. Proc Natl Acad Sci U S A 89: 10218-10221.
19. Wong RC, Pera MF, Pebay A, (2008) Role of gap junctions in embryonic and somatic stem cells. Stem Cell Rev 4: 283-292.
20. Vinken M, Vanhaecke T, Papeleu P, Snykers S, Henkens T, et al. (2006) Connexins and their channels in cell growth and cell death. Cell Signal 18: 592-600.
21. Wei CJ, Xu X, Lo CW, (2004) Connexins and cell signaling in development and disease. Annu Rev Cell Dev Biol 20: 811-838.
22. Krysko DV, Leybaert L, Vandenabeele P, D'Herde K, (2005) Gap junctions and the propagation of cell survival and cell death signals. Apoptosis 10: 459-469.
23. Alldredge B, (2008) Clinical connexions. J Clin Pathol 61: 885-890.
24. Yamasaki H, (1990) Gap junctional intercellular communication and carcinogenesis. Carcinogenesis 11: 1051-1058.
25. Yamasaki H, Mesnil M, Omori Y, Mironov N, Krutovskikh V, (1995) Intercellular communication and carcinogenesis. Mutat Res 333: 181-188.
26. Laird DW, Fistouris P, Batist G, Alpert L, Huynh HT, et al. (1999) Deficiency of connexin43 gap junctions is an independent marker for breast tumors. Cancer Res 59: 4104-4110.
27. Nicolson GL, Dulski KM, Trosko JE, (1988) Loss of intercellular junctional communication correlates with metastatic potential in mammary adenocarcinoma cells. Proc Natl Acad Sci U S A 85: 473-476.
28. Lee SW, Tomasetto C, Paul D, Keyomarsi K, Sager R, (1992) Transcriptional downregulation of gap-junction proteins blocks junctional communication in human mammary tumor cell lines. J Cell Biol 118: 1213-1221.
29. Holden PR, McGuire B, Stoler A, Balmain A, Pitts JD, (1997) Changes in gap junctional intercellular communication in mouse skin carcinogenesis. Carcinogenesis 18: 15-21.
30. Albright CD, Jones RT, Grimley PM, Resau JH, (1990) Intercellular communication in bronchial epithelial cells: review of evidence for a possible role in lung carcinogenesis. Toxicol Pathol 18: 324-341.
31. Tsai H, Werber J, Davia MO, Edelman M, Tanaka KE, et al. (1996) Reduced connexin 43 expression in high grade, human prostatic adenocarcinoma cells. Biochem Biophys Res Commun 227: 64-69.
32. Huang RP, Hossain MZ, Sehgal A, Boynton AL, (1999) Reduced connexin43 expression in high-grade human brain glioma cells. J Surg Oncol 70: 21-24.
33. Umhauer S, Ruch RJ, Fanning J, (2000) Gap junctional intercellular communication and connexin 43 expression in ovarian carcinoma. Am J Obstet Gynecol 182: 999-1000.
34. Hossain MZ, Ao P, Boynton AL, (1998) Platelet-derived growth factor-induced disruption of gap junctional communication and phosphorylation of connexin43 involves protein kinase C and mitogen-activated protein kinase. Journal of Cellular Physiology 176: 332-341.
35. Hofer A, Saez JC, Chang CC, Trosko JE, Spray DC, et al. (1996) C-erbB2/neu transfection induces gap junctional communication incompetence in glial cells. Journal of Neuroscience 16: 4311-4321.
36. Brissette JL, Kumar NM, Gilula NB, Dotto GP, (1991) The Tumor Promoter 12-O-Tetradecanoylphorbol-13-Acetate and the Ras Oncogene Modulate Expression and Phosphorylation of Gap Junction Proteins. Molecular and Cellular Biology 11: 5364-5371.
37. Tomakidi P, Cheng H, Kohl A, Komposch G, Alonso A, (2000) Connexin 43 expression is downregulated in raft cultures of human keratinocytes expressing the human papillomavirus type 16 E5 protein. Cell and Tissue Research 301: 323-327.
38. Bao XP, Clark CB, Frangos JA, (2000) Temporal gradient in sheer-induced signaling pathway: involvement of MAP kinase, c-fos, and connexin43. American Journal of Physiology-Heart and Circulatory Physiology 278: H1598-H1605.
39. Hossain MZ, Jagdale AB, Ao P, Kazlauskas A, Boynton AL, (1999) Disruption of gap junctional communication by the platelet-derived growth factor is mediated via multiple signaling pathways. Journal of Biological Chemistry 274: 10489-10496.
40. Hossain MZ, Jagdale AB, Ao P, Boynton AL, (1999) Mitogen-activated protein kinase and phosphorylation of connexin43 are not sufficient for the disruption of gap junctional communication by platelet-derived growth factor and tetradecanoylphorbol acetate. Journal of Cellular Physiology 179: 87-96.
41. Warn-Cramer BJ, Cottrell GT, Burt JM, Lau AF, (1998) Regulation of connexin-43 gap junctional intercellular communication by mitogen-activated protein kinase. Journal of Biological Chemistry 273: 9188-9196.
42. WarnCramer BJ, Lampe PD, Kurata WE, Kanemitsu MY, Loo LWM, et al. (1996) Characterization of the mitogen-activated protein kinase phosphorylation sites on the connexin-43 gap junction protein. Journal of Biological Chemistry 271: 3779-3786.
43. Carystinos GD, Kandouz M, Alaoui-Jamali MA, Batist G, (2003) Unexpected induction of the human connexin 43 promoter by the ras signaling pathway is mediated by a novel putative promoter sequence. Mol Pharmacol 63: 821-831.
44. Pesole G, Liuni S, Grillo G, Licciulli F, Mignone F, et al. (2002) UTRdb and UTRsite: specialized databases of sequences and functional elements of 5′ and 3′ untranslated regions of eukaryotic mRNAs. Update 2002. Nucleic Acids Res 30: 335-340.
45. Mignone F, Gissi C, Liuni S, Pesole G, (2002) Untranslated regions of mRNAs. Genome Biol 3: REVIEWS0004.
46. Schiavi A, Hudder A, Werner R, (1999) Connexin43 mRNA contains a functional internal ribosome entry site. FEBS Lett 464: 118-122.
47. Lahlou H, Fanjul M, Pradayrol L, Susini C, Pyronnet S, (2005) Restoration of functional gap junctions through internal ribosome entry site-dependent synthesis of endogenous connexins in density-inhibited cancer cells. Mol Cell Biol 25: 4034-4045.
48. Pfeifer I, Anderson C, Werner R, Oltra E, (2004) Redefining the structure of the mouse connexin43 gene: selective promoter usage and alternative splicing mechanisms yield transcripts with different translational efficiencies. Nucleic Acids Res 32: 4550-4562.
49. Kandouz M, Bier A, Carystinos GD, Alaoui-Jamali MA, Batist G, (2004) Connexin43 pseudogene is expressed in tumor cells and inhibits growth. Oncogene 23: 4763-4770.
50. Klotz LO (2012) Posttranscriptional regulation of connexin-43 expression. Arch Biochem Biophys 524: 23-29. S0003-9861(12)00103-8 [pii];10.1016/j.abb.2012.03.012 [doi].
51. Anderson C, Catoe H, Werner R (2006) MIR-206 regulates connexin43 expression during skeletal muscle development. Nucleic Acids Res 34: 5863-5871. gkl743 [pii];10.1093/nar/gkl743 [doi].
52. Yang B, Lin H, Xiao J, Lu Y, Luo X, et al. (2007) The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nat Med 13: 486-491. nm1569 [pii];10.1038/nm1569 [doi].
53. Inose H (2009) A microRNA regulatory mechanism of osteoblast differentiation.
54. Kedde M, Strasser MJ, Boldajipour B, Oude Vrielink JA, Slanchev K, et al. (2007) RNA-binding protein Dnd1 inhibits microRNA access to target mRNA. Cell 131: 1273-1286. S0092-8674(07)01537-1 [pii];10.1016/j.cell.2007.11.034 [doi].
55. Gregory LA, Ricart RA, Patel SA, Lim PK, Rameshwar P (2011) microRNAs, Gap Junctional Intercellular Communication and Mesenchymal Stem Cells in Breast Cancer Metastasis. Curr Cancer Ther Rev 7: 176-183. 10.2174/157339411796234915 [doi].
56. Greco SJ (2012) A reporter assay to detect transfer and targeting of miRNAs in stem cell-breast cancer co-cultures.
57. Lim PK (2011) Gap junction-mediated import of microRNA from bone marrow stromal cells can elicit cell cycle quiescence in breast cancer cells.
58. Ji X, Kong J, Carstens RP, Liebhaber SA, (2007) The 3′ untranslated region complex involved in stabilization of human alpha-globin mRNA assembles in the nucleus and serves an independent role as a splice enhancer. Mol Cell Biol 27: 3290-3302.
59. Makeyev AV, Liebhaber SA, (2002) The poly(C)-binding proteins: a multiplicity of functions and a search for mechanisms. RNA 8: 265-278.
60. Choi HS, Hwang CK, Song KY, Law PY, Wei LN, et al. (2009) Poly(C)-binding proteins as transcriptional regulators of gene expression. Biochem Biophys Res Commun 380: 431-436. S0006-291X(09)00192-2 [pii];10.1016/j.bbrc.2009.01.136 [doi].
61. Kumaran RI, Muralikrishna B, Parnaik VK, (2002) Lamin A/C speckles mediate spatial organization of splicing factor compartments and RNA polymerase II transcription. J Cell Biol 159: 783-793.
62. Jagatheesan G, Thanumalayan S, Muralikrishna B, Rangaraj N, Karande AA, et al. (1999) Colocalization of intranuclear lamin foci with RNA splicing factors. J Cell Sci 112 (Pt 24): 4651-4661.
63. Dechat T, Pfleghaar K, Sengupta K, Shimi T, Shumaker DK, et al. (2008) Nuclear lamins: major factors in the structural organization and function of the nucleus and chromatin. Genes Dev 22: 832-853.
64. Challa AA, Stefanovic B (2011) A novel role of vimentin filaments: binding and stabilization of collagen mRNAs. Mol Cell Biol 31: 3773-3789. MCB.05263-11 [pii];10.1128/MCB.05263-11 [doi].
65. Andersen JS, Lam YW, Leung AK, Ong SE, Lyon CE, et al. (2005) Nucleolar proteome dynamics. Nature 433: 77-83.
66. Lewis JD, Tollervey D, (2000) Like attracts like: getting RNA processing together in the nucleus. Science 288: 1385-1389.
67. Lewis BP, Green RE, Brenner SE, (2003) Evidence for the widespread coupling of alternative splicing and nonsense-mediated mRNA decay in humans. Proc Natl Acad Sci U S A 100: 189-192.
68. Ma XM, Yoon SO, Richardson CJ, Julich K, Blenis J, (2008) SKAR links pre-mRNA splicing to mTOR/S6K1-mediated enhanced translation efficiency of spliced mRNAs. Cell 133: 303-313.
69. Isken O, Kim YK, Hosoda N, Mayeur GL, Hershey JW, et al. (2008) Upf1 phosphorylation triggers translational repression during nonsense-mediated mRNA decay. Cell 133: 314-327.
70. Fuller-Pace FV, (2006) DExD/H box RNA helicases: multifunctional proteins with important roles in transcriptional regulation. Nucleic Acids Res 34: 4206-4215.
71. Fuller-Pace FV, Nicol SM (2012) DEAD-box RNA helicases as transcription cofactors. Methods Enzymol 511: 347-367. B978-0-12-396546-2.00016-4 [pii];10.1016/B978-0-12-396546-2.00016-4 [doi].
72. Lee CG, (2002) RH70, a bidirectional RNA helicase, co-purifies with U1snRNP. J Biol Chem 277: 39679-39683.
73. Auboeuf D, Dowhan DH, Dutertre M, Martin N, Berget SM, et al. (2005) A subset of nuclear receptor coregulators act as coupling proteins during synthesis and maturation of RNA transcripts. Mol Cell Biol 25: 5307-5316.
74. Laroia G, Cuesta R, Brewer G, Schneider RJ, (1999) Control of mRNA decay by heat shock-ubiquitin-proteasome pathway. Science 284: 499-502.
75. Matsui H, Asou H, Inaba T, (2007) Cytokines direct the regulation of Bim mRNA stability by heat-shock cognate protein 70. Mol Cell 25: 99-112.
76. Fox AH, Lam YW, Leung AK, Lyon CE, Andersen J, et al. (2002) Paraspeckles: a novel nuclear domain. Curr Biol 12: 13-25.
77. Bond CS, Fox AH, (2009) Paraspeckles: nuclear bodies built on long noncoding RNA. J Cell Biol 186: 637-644.